Supporting Clinical Trials Phase 1-3

20/20 Onsite’s support for clinical trials stands apart from traditional, fixed-location sites due to its innovative approach, tailored to enhance participant accessibility, data quality, and trial efficiency. Here’s how 20/20 Onsite is different from legacy sites:

1. Point-of-Need Accessibility: Unlike legacy sites, which require participants to travel, 20/20 Onsite brings state-of-the-art, point-of-need ophthalmic assessments directly to trial participants wherever they are—home, work, or even school.
2. Patient-Centric Model: By minimizing patient travel and scheduling inconvenience, 20/20 Onsite increases engagement and retention. Our point-of-need clinics help ensure trials stay on track with high participant satisfaction and a 90+ Net Promoter Score.
3. Enhanced Enrollment and Diversity: Fixed-location sites often limit access to patients within a specific geography, resulting in the underrepresentation of diverse populations. 20/20 Onsite’s point-of-need clinics enable recruitment from a broader and more diverse demographic, addressing a crucial need in clinical trials to meet enrollment goals effectively. 
4. Cost Control and Efficiency: Trial delays can cost sponsors millions daily. 20/20 Onsite's point-of-need service model is designed to meet strict timelines, reduce logistical delays, and enable sponsors to manage budgets better. 

Overall, 20/20 Onsite offers a streamlined, patient-centered alternative that overcomes the traditional limitations of fixed-location clinical trial sites.

20/20 Onsite’s point-of-need service model eliminates the significant barriers that traditional fixed-location sites face, offering pinpoint accessibility and predictable timing by reaching trial participants exactly where they live or work. Reaching participants is especially critical when 80% of clinical trials fail to meet enrollment timelines and 30% of participants drop out, with a cost that can reach thousands of dollars per patient. By delivering assessments directly to participants, 20/20 Onsite reduces selection bias, expands trial reach, accelerates enrollment, and minimizes dropout rates—ensuring trials are completed on time and on budget.

On the other hand, legacy sites rely solely on motivated patients who can travel, a necessity that limits diversity and increases recruitment challenges. 20/20 Onsite’s Net Promoter Score of 90+ reflects high participant satisfaction, boosting retention and engagement throughout the study.

Additionally, legacy sites often struggle to reach underserved or remote populations. However, 20/20 Onsite eliminates this issue by providing point-of-need clinics, delivering high-quality, patient-centric care anywhere needed. This flexibility improves patient satisfaction and enhances trial integrity and data quality, making our service a cost-effective and superior solution for clinical trials.